Selected research
Market Outlook & Growth Opportunities
Global Digital Endocrine Disease Management Market Outlook and Growth Opportunities 2026
Market perspective
The global Digital Endocrine Disease Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Digital Endocrine Disease Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Digital Endocrine Disease Management market include Abbott Diabetes Care, Dexcom Inc, Vida Health, Welldoc, Lark Health, Roche Diabetes Care, Oviva AG, Kaia Health and CureApp Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Digital Endocrine Disease Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Digital Endocrine Disease Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Digital Endocrine Disease Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Endocrine Disease Management market.
Digital Endocrine Disease Management Segment by Company
Abbott Diabetes Care
Dexcom Inc
Vida Health
Welldoc
Lark Health
Roche Diabetes Care
Oviva AG
Kaia Health
CureApp Inc
Welby Inc
Ubie Inc
TeleMed2U
Twin Health
eddii-Care
DocVilla
Novo Nordisk Digital Health
Shangyi Technology
JD Health
Alibaba Health
Teladoc Health
Omada Health
Virta Health
Digital Endocrine Disease Management Segment by Type
Diabetes Management
Thyroid Disease Management
Obesity and Metabolic Disorder Management
PCOS Management
Osteoporosis Management
Others
Digital Endocrine Disease Management Segment by Application
Consumer Health
Chronic Disease Management
Hospital Digital Care
Employer Wellness
Others
Digital Endocrine Disease Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Digital Endocrine Disease Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Digital Endocrine Disease Management key companies, revenue, market share, and recent developments.
3. To split the Digital Endocrine Disease Management breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Digital Endocrine Disease Management market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Digital Endocrine Disease Management significant trends, drivers, influence factors in global and regions.
6. To analyze Digital Endocrine Disease Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Endocrine Disease Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Endocrine Disease Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Endocrine Disease Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Endocrine Disease Management industry.
Chapter 3: Detailed analysis of Digital Endocrine Disease Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Digital Endocrine Disease Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Digital Endocrine Disease Management in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Digital Endocrine Disease Management Industry Trends
Table 2. Digital Endocrine Disease Management Industry Drivers
Table 3. Digital Endocrine Disease Management Industry Opportunities and Challenges
Table 4. Digital Endocrine Disease Management Industry Restraints
Table 5. Global Digital Endocrine Disease Management Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Digital Endocrine Disease Management Revenue Share by Company (2021-2026)
Table 7. Global Digital Endocrine Disease Management Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Digital Endocrine Disease Management Key Company Manufacturing Base & Headquarters
Table 9. Global Digital Endocrine Disease Management Company, Product Type & Application
Table 10. Global Digital Endocrine Disease Management Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Digital Endocrine Disease Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Diabetes Management
Table 15. Significant Companies of Thyroid Disease Management
Table 16. Significant Companies of Obesity and Metabolic Disorder Management
Table 17. Significant Companies of PCOS Management
Table 18. Significant Companies of Osteoporosis Management
Table 19. Significant Companies of Others
Table 20. Global Digital Endocrine Disease Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 21. Global Digital Endocrine Disease Management Sales Value by Type (2021-2026) & (US$ Million)
Table 22. Global Digital Endocrine Disease Management Sales Value by Type (2027-2032) & (US$ Million)
Table 23. Global Digital Endocrine Disease Management Sales Value Share by Type (2021-2026)
Table 24. Global Digital Endocrine Disease Management Sales Value Share by Type (2027-2032)
Table 25. Significant Companies of Consumer Health
Table 26. Significant Companies of Chronic Disease Management
Table 27. Significant Companies of Hospital Digital Care
Table 28. Significant Companies of Employer Wellness
Table 29. Significant Companies of Others
Table 30. Global Digital Endocrine Disease Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Digital Endocrine Disease Management Sales Value by Application (2021-2026) & (US$ Million)
Table 32. Global Digital Endocrine Disease Management Sales Value by Application (2027-2032) & (US$ Million)
Table 33. Global Digital Endocrine Disease Management Sales Value Share by Application (2021-2026)
Table 34. Global Digital Endocrine Disease Management Sales Value Share by Application (2027-2032)
Table 35. Global Digital Endocrine Disease Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 36. Global Digital Endocrine Disease Management Sales Value by Region (2021-2026) & (US$ Million)
Table 37. Global Digital Endocrine Disease Management Sales Value Share by Region (2021-2026)
Table 38. Global Digital Endocrine Disease Management Sales Value by Region (2027-2032) & (US$ Million)
Table 39. Global Digital Endocrine Disease Management Sales Value Share by Region (2027-2032)
Table 40. Global Digital Endocrine Disease Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 41. Global Digital Endocrine Disease Management Sales Value by Country (2021-2026) & (US$ Million)
Table 42. Global Digital Endocrine Disease Management Sales Value Market Share by Country (2021-2026)
Table 43. Global Digital Endocrine Disease Management Sales Value by Country (2027-2032) & (US$ Million)
Table 44. Global Digital Endocrine Disease Management Sales Value Market Share by Country (2027-2032)
Table 45. Abbott Diabetes Care Company Information
Table 46. Abbott Diabetes Care Business Overview
Table 47. Abbott Diabetes Care Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 48. Abbott Diabetes Care Digital Endocrine Disease Management Product Portfolio
Table 49. Abbott Diabetes Care Recent Development
Table 50. Dexcom Inc Company Information
Table 51. Dexcom Inc Business Overview
Table 52. Dexcom Inc Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Dexcom Inc Digital Endocrine Disease Management Product Portfolio
Table 54. Dexcom Inc Recent Development
Table 55. Vida Health Company Information
Table 56. Vida Health Business Overview
Table 57. Vida Health Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 58. Vida Health Digital Endocrine Disease Management Product Portfolio
Table 59. Vida Health Recent Development
Table 60. Welldoc Company Information
Table 61. Welldoc Business Overview
Table 62. Welldoc Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 63. Welldoc Digital Endocrine Disease Management Product Portfolio
Table 64. Welldoc Recent Development
Table 65. Lark Health Company Information
Table 66. Lark Health Business Overview
Table 67. Lark Health Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Lark Health Digital Endocrine Disease Management Product Portfolio
Table 69. Lark Health Recent Development
Table 70. Roche Diabetes Care Company Information
Table 71. Roche Diabetes Care Business Overview
Table 72. Roche Diabetes Care Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Roche Diabetes Care Digital Endocrine Disease Management Product Portfolio
Table 74. Roche Diabetes Care Recent Development
Table 75. Oviva AG Company Information
Table 76. Oviva AG Business Overview
Table 77. Oviva AG Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Oviva AG Digital Endocrine Disease Management Product Portfolio
Table 79. Oviva AG Recent Development
Table 80. Kaia Health Company Information
Table 81. Kaia Health Business Overview
Table 82. Kaia Health Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Kaia Health Digital Endocrine Disease Management Product Portfolio
Table 84. Kaia Health Recent Development
Table 85. CureApp Inc Company Information
Table 86. CureApp Inc Business Overview
Table 87. CureApp Inc Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. CureApp Inc Digital Endocrine Disease Management Product Portfolio
Table 89. CureApp Inc Recent Development
Table 90. Welby Inc Company Information
Table 91. Welby Inc Business Overview
Table 92. Welby Inc Digital Endocrine Disease Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Welby Inc Digital Endocrine Disease Management Product Portfolio
Table 94. Welby Inc Recent Development
Table 95. Ubie Inc Company Information
Table 96. Ubie Inc Business Overview
Table 97. Ubie Inc Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 98. Ubie Inc Digital Endocrine Disease Management Product Portfolio
Table 99. Ubie Inc Recent Development
Table 100. TeleMed2U Company Information
Table 101. TeleMed2U Business Overview
Table 102. TeleMed2U Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 103. TeleMed2U Digital Endocrine Disease Management Product Portfolio
Table 104. TeleMed2U Recent Development
Table 105. Twin Health Company Information
Table 106. Twin Health Business Overview
Table 107. Twin Health Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 108. Twin Health Digital Endocrine Disease Management Product Portfolio
Table 109. Twin Health Recent Development
Table 110. eddii-Care Company Information
Table 111. eddii-Care Business Overview
Table 112. eddii-Care Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 113. eddii-Care Digital Endocrine Disease Management Product Portfolio
Table 114. eddii-Care Recent Development
Table 115. DocVilla Company Information
Table 116. DocVilla Business Overview
Table 117. DocVilla Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 118. DocVilla Digital Endocrine Disease Management Product Portfolio
Table 119. DocVilla Recent Development
Table 120. Novo Nordisk Digital Health Company Information
Table 121. Novo Nordisk Digital Health Business Overview
Table 122. Novo Nordisk Digital Health Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 123. Novo Nordisk Digital Health Digital Endocrine Disease Management Product Portfolio
Table 124. Novo Nordisk Digital Health Recent Development
Table 125. Shangyi Technology Company Information
Table 126. Shangyi Technology Business Overview
Table 127. Shangyi Technology Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 128. Shangyi Technology Digital Endocrine Disease Management Product Portfolio
Table 129. Shangyi Technology Recent Development
Table 130. JD Health Company Information
Table 131. JD Health Business Overview
Table 132. JD Health Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 133. JD Health Digital Endocrine Disease Management Product Portfolio
Table 134. JD Health Recent Development
Table 135. Alibaba Health Company Information
Table 136. Alibaba Health Business Overview
Table 137. Alibaba Health Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 138. Alibaba Health Digital Endocrine Disease Management Product Portfolio
Table 139. Alibaba Health Recent Development
Table 140. Teladoc Health Company Information
Table 141. Teladoc Health Business Overview
Table 142. Teladoc Health Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 143. Teladoc Health Digital Endocrine Disease Management Product Portfolio
Table 144. Teladoc Health Recent Development
Table 145. Omada Health Company Information
Table 146. Omada Health Business Overview
Table 147. Omada Health Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 148. Omada Health Digital Endocrine Disease Management Product Portfolio
Table 149. Omada Health Recent Development
Table 150. Virta Health Company Information
Table 151. Virta Health Business Overview
Table 152. Virta Health Digital Endocrine Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 153. Virta Health Digital Endocrine Disease Management Product Portfolio
Table 154. Virta Health Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Authors List of This Report
Table 157. Secondary Sources
Table 158. Primary Sources
List of Figures
Figure 1. Digital Endocrine Disease Management Product Image
Figure 2. Global Digital Endocrine Disease Management Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Digital Endocrine Disease Management Market Size (2021-2032) & (US$ Million)
Figure 4. Global Digital Endocrine Disease Management Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Diabetes Management Image
Figure 8. Thyroid Disease Management Image
Figure 9. Obesity and Metabolic Disorder Management Image
Figure 10. PCOS Management Image
Figure 11. Osteoporosis Management Image
Figure 12. Others Image
Figure 13. Global Digital Endocrine Disease Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 14. Global Digital Endocrine Disease Management Sales Value Share 2021 VS 2025 VS 2032
Figure 15. Global Digital Endocrine Disease Management Sales Value Share by Type (2021-2032)
Figure 16. Consumer Health Image
Figure 17. Chronic Disease Management Image
Figure 18. Hospital Digital Care Image
Figure 19. Employer Wellness Image
Figure 20. Others Image
Figure 21. Global Digital Endocrine Disease Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 22. Global Digital Endocrine Disease Management Sales Value Share 2021 VS 2025 VS 2032
Figure 23. Global Digital Endocrine Disease Management Sales Value Share by Application (2021-2032)
Figure 24. Global Digital Endocrine Disease Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 25. Global Digital Endocrine Disease Management Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 26. North America Digital Endocrine Disease Management Sales Value (2021-2032) & (US$ Million)
Figure 27. North America Digital Endocrine Disease Management Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Europe Digital Endocrine Disease Management Sales Value (2021-2032) & (US$ Million)
Figure 29. Europe Digital Endocrine Disease Management Sales Value Share by Country (%), 2025 VS 2032
Figure 30. Asia-Pacific Digital Endocrine Disease Management Sales Value (2021-2032) & (US$ Million)
Figure 31. Asia-Pacific Digital Endocrine Disease Management Sales Value Share by Country (%), 2025 VS 2032
Figure 32. South America Digital Endocrine Disease Management Sales Value (2021-2032) & (US$ Million)
Figure 33. South America Digital Endocrine Disease Management Sales Value Share by Country (%), 2025 VS 2032
Figure 34. Middle East & Africa Digital Endocrine Disease Management Sales Value (2021-2032) & (US$ Million)
Figure 35. Middle East & Africa Digital Endocrine Disease Management Sales Value Share by Country (%), 2025 VS 2032
Figure 36. USA Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. USA Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. USA Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Canada Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Canada Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Canada Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Mexico Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Mexico Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Mexico Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. Germany Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. Germany Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. Germany Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. France Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. France Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. France Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. U.K. Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. U.K. Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. U.K. Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Italy Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Italy Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Italy Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Spain Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Spain Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Spain Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Russia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Russia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Russia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Netherlands Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Netherlands Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Netherlands Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Nordic Countries Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Nordic Countries Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Nordic Countries Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. China Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. China Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. China Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. Japan Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. Japan Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. Japan Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. South Korea Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. South Korea Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. South Korea Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. India Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. India Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. India Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Australia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Australia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Australia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Southeast Asia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Southeast Asia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Southeast Asia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Brazil Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Brazil Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Brazil Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Argentina Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Argentina Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Argentina Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Chile Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Chile Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Chile Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Colombia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Colombia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Colombia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Peru Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Peru Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Peru Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Saudi Arabia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Saudi Arabia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Saudi Arabia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Israel Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Israel Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Israel Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. UAE Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. UAE Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. UAE Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Turkey Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Turkey Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Turkey Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Iran Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Iran Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Iran Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Egypt Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 118. Egypt Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 119. Egypt Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 120. Years Considered
Figure 121. Research Process
Figure 122. Key Executives Interviewed
Scope & coverage.
Types
- Diabetes Management
- Thyroid Disease Management
- Obesity and Metabolic Disorder Management
- PCOS Management
- Osteoporosis Management
- Others
Applications
- Consumer Health
- Chronic Disease Management
- Hospital Digital Care
- Employer Wellness
- Others
Companies covered
- Abbott Diabetes Care
- Dexcom Inc
- Vida Health
- Welldoc
- Lark Health
- Roche Diabetes Care
- Oviva AG
- Kaia Health
- CureApp Inc
- Welby Inc
- Ubie Inc
- TeleMed2U
- Twin Health
- eddii-Care
- DocVilla
- Novo Nordisk Digital Health
- Shangyi Technology
- JD Health
- Alibaba Health
- Teladoc Health
- Omada Health
- Virta Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Digital Endocrine Disease Management Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Digital Endocrine Disease Management Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Digital Endocrine Disease Management Market Dynamics
- 2.1 Digital Endocrine Disease Management Industry Trends
- 2.2 Digital Endocrine Disease Management Industry Drivers
- 2.3 Digital Endocrine Disease Management Industry Opportunities and Challenges
- 2.4 Digital Endocrine Disease Management Industry Restraints
3 Digital Endocrine Disease Management Market by Company
- 3.1 Global Digital Endocrine Disease Management Company Revenue Ranking in 2025
- 3.2 Global Digital Endocrine Disease Management Revenue by Company (2021-2026)
- 3.3 Global Digital Endocrine Disease Management Company Ranking (2024-2026)
- 3.4 Global Digital Endocrine Disease Management Company Manufacturing Base and Headquarters
- 3.5 Global Digital Endocrine Disease Management Company Product Type and Application
- 3.6 Global Digital Endocrine Disease Management Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Digital Endocrine Disease Management Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Digital Endocrine Disease Management Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Digital Endocrine Disease Management Market by Type
- 4.1 Digital Endocrine Disease Management Type Introduction
- 4.1.1 Diabetes Management
- 4.1.2 Thyroid Disease Management
- 4.1.3 Obesity and Metabolic Disorder Management
- 4.1.4 PCOS Management
- 4.1.5 Osteoporosis Management
- 4.1.6 Others
- 4.2 Global Digital Endocrine Disease Management Sales Value by Type
- 4.2.1 Global Digital Endocrine Disease Management Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Digital Endocrine Disease Management Sales Value by Type (2021-2032)
- 4.2.3 Global Digital Endocrine Disease Management Sales Value Share by Type (2021-2032)
5 Digital Endocrine Disease Management Market by Application
- 5.1 Digital Endocrine Disease Management Application Introduction
- 5.1.1 Consumer Health
- 5.1.2 Chronic Disease Management
- 5.1.3 Hospital Digital Care
- 5.1.4 Employer Wellness
- 5.1.5 Others
- 5.2 Global Digital Endocrine Disease Management Sales Value by Application
- 5.2.1 Global Digital Endocrine Disease Management Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Digital Endocrine Disease Management Sales Value by Application (2021-2032)
- 5.2.3 Global Digital Endocrine Disease Management Sales Value Share by Application (2021-2032)
6 Digital Endocrine Disease Management Regional Value Analysis
- 6.1 Global Digital Endocrine Disease Management Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Digital Endocrine Disease Management Sales Value by Region (2021-2032)
- 6.2.1 Global Digital Endocrine Disease Management Sales Value by Region: 2021-2026
- 6.2.2 Global Digital Endocrine Disease Management Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Digital Endocrine Disease Management Sales Value (2021-2032)
- 6.3.2 North America Digital Endocrine Disease Management Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Digital Endocrine Disease Management Sales Value (2021-2032)
- 6.4.2 Europe Digital Endocrine Disease Management Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Digital Endocrine Disease Management Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Digital Endocrine Disease Management Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Digital Endocrine Disease Management Sales Value (2021-2032)
- 6.6.2 South America Digital Endocrine Disease Management Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Digital Endocrine Disease Management Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Digital Endocrine Disease Management Sales Value Share by Country, 2025 VS 2032
7 Digital Endocrine Disease Management Country-level Value Analysis
- 7.1 Global Digital Endocrine Disease Management Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Digital Endocrine Disease Management Sales Value by Country (2021-2032)
- 7.2.1 Global Digital Endocrine Disease Management Sales Value by Country (2021-2026)
- 7.2.2 Global Digital Endocrine Disease Management Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.7.2 France Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.14.2 China Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.17.2 India Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Digital Endocrine Disease Management Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Digital Endocrine Disease Management Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Digital Endocrine Disease Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Diabetes Care
- 8.1.1 Abbott Diabetes Care Company Information
- 8.1.2 Abbott Diabetes Care Business Overview
- 8.1.3 Abbott Diabetes Care Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Diabetes Care Digital Endocrine Disease Management Product Portfolio
- 8.1.5 Abbott Diabetes Care Recent Developments
- 8.2 Dexcom Inc
- 8.2.1 Dexcom Inc Company Information
- 8.2.2 Dexcom Inc Business Overview
- 8.2.3 Dexcom Inc Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.2.4 Dexcom Inc Digital Endocrine Disease Management Product Portfolio
- 8.2.5 Dexcom Inc Recent Developments
- 8.3 Vida Health
- 8.3.1 Vida Health Company Information
- 8.3.2 Vida Health Business Overview
- 8.3.3 Vida Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.3.4 Vida Health Digital Endocrine Disease Management Product Portfolio
- 8.3.5 Vida Health Recent Developments
- 8.4 Welldoc
- 8.4.1 Welldoc Company Information
- 8.4.2 Welldoc Business Overview
- 8.4.3 Welldoc Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.4.4 Welldoc Digital Endocrine Disease Management Product Portfolio
- 8.4.5 Welldoc Recent Developments
- 8.5 Lark Health
- 8.5.1 Lark Health Company Information
- 8.5.2 Lark Health Business Overview
- 8.5.3 Lark Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.5.4 Lark Health Digital Endocrine Disease Management Product Portfolio
- 8.5.5 Lark Health Recent Developments
- 8.6 Roche Diabetes Care
- 8.6.1 Roche Diabetes Care Company Information
- 8.6.2 Roche Diabetes Care Business Overview
- 8.6.3 Roche Diabetes Care Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.6.4 Roche Diabetes Care Digital Endocrine Disease Management Product Portfolio
- 8.6.5 Roche Diabetes Care Recent Developments
- 8.7 Oviva AG
- 8.7.1 Oviva AG Company Information
- 8.7.2 Oviva AG Business Overview
- 8.7.3 Oviva AG Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.7.4 Oviva AG Digital Endocrine Disease Management Product Portfolio
- 8.7.5 Oviva AG Recent Developments
- 8.8 Kaia Health
- 8.8.1 Kaia Health Company Information
- 8.8.2 Kaia Health Business Overview
- 8.8.3 Kaia Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.8.4 Kaia Health Digital Endocrine Disease Management Product Portfolio
- 8.8.5 Kaia Health Recent Developments
- 8.9 CureApp Inc
- 8.9.1 CureApp Inc Company Information
- 8.9.2 CureApp Inc Business Overview
- 8.9.3 CureApp Inc Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.9.4 CureApp Inc Digital Endocrine Disease Management Product Portfolio
- 8.9.5 CureApp Inc Recent Developments
- 8.10 Welby Inc
- 8.10.1 Welby Inc Company Information
- 8.10.2 Welby Inc Business Overview
- 8.10.3 Welby Inc Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.10.4 Welby Inc Digital Endocrine Disease Management Product Portfolio
- 8.10.5 Welby Inc Recent Developments
- 8.11 Ubie Inc
- 8.11.1 Ubie Inc Company Information
- 8.11.2 Ubie Inc Business Overview
- 8.11.3 Ubie Inc Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.11.4 Ubie Inc Digital Endocrine Disease Management Product Portfolio
- 8.11.5 Ubie Inc Recent Developments
- 8.12 TeleMed2U
- 8.12.1 TeleMed2U Company Information
- 8.12.2 TeleMed2U Business Overview
- 8.12.3 TeleMed2U Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.12.4 TeleMed2U Digital Endocrine Disease Management Product Portfolio
- 8.12.5 TeleMed2U Recent Developments
- 8.13 Twin Health
- 8.13.1 Twin Health Company Information
- 8.13.2 Twin Health Business Overview
- 8.13.3 Twin Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.13.4 Twin Health Digital Endocrine Disease Management Product Portfolio
- 8.13.5 Twin Health Recent Developments
- 8.14 eddii-Care
- 8.14.1 eddii-Care Company Information
- 8.14.2 eddii-Care Business Overview
- 8.14.3 eddii-Care Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.14.4 eddii-Care Digital Endocrine Disease Management Product Portfolio
- 8.14.5 eddii-Care Recent Developments
- 8.15 DocVilla
- 8.15.1 DocVilla Company Information
- 8.15.2 DocVilla Business Overview
- 8.15.3 DocVilla Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.15.4 DocVilla Digital Endocrine Disease Management Product Portfolio
- 8.15.5 DocVilla Recent Developments
- 8.16 Novo Nordisk Digital Health
- 8.16.1 Novo Nordisk Digital Health Company Information
- 8.16.2 Novo Nordisk Digital Health Business Overview
- 8.16.3 Novo Nordisk Digital Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.16.4 Novo Nordisk Digital Health Digital Endocrine Disease Management Product Portfolio
- 8.16.5 Novo Nordisk Digital Health Recent Developments
- 8.17 Shangyi Technology
- 8.17.1 Shangyi Technology Company Information
- 8.17.2 Shangyi Technology Business Overview
- 8.17.3 Shangyi Technology Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.17.4 Shangyi Technology Digital Endocrine Disease Management Product Portfolio
- 8.17.5 Shangyi Technology Recent Developments
- 8.18 JD Health
- 8.18.1 JD Health Company Information
- 8.18.2 JD Health Business Overview
- 8.18.3 JD Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.18.4 JD Health Digital Endocrine Disease Management Product Portfolio
- 8.18.5 JD Health Recent Developments
- 8.19 Alibaba Health
- 8.19.1 Alibaba Health Company Information
- 8.19.2 Alibaba Health Business Overview
- 8.19.3 Alibaba Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.19.4 Alibaba Health Digital Endocrine Disease Management Product Portfolio
- 8.19.5 Alibaba Health Recent Developments
- 8.20 Teladoc Health
- 8.20.1 Teladoc Health Company Information
- 8.20.2 Teladoc Health Business Overview
- 8.20.3 Teladoc Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.20.4 Teladoc Health Digital Endocrine Disease Management Product Portfolio
- 8.20.5 Teladoc Health Recent Developments
- 8.21 Omada Health
- 8.21.1 Omada Health Company Information
- 8.21.2 Omada Health Business Overview
- 8.21.3 Omada Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.21.4 Omada Health Digital Endocrine Disease Management Product Portfolio
- 8.21.5 Omada Health Recent Developments
- 8.22 Virta Health
- 8.22.1 Virta Health Company Information
- 8.22.2 Virta Health Business Overview
- 8.22.3 Virta Health Digital Endocrine Disease Management Revenue and Gross Margin (2021-2026)
- 8.22.4 Virta Health Digital Endocrine Disease Management Product Portfolio
- 8.22.5 Virta Health Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst